HANSOH PHARMAC.21/26 CVHANSOH PHARMAC.21/26 CVHANSOH PHARMAC.21/26 CV

HANSOH PHARMAC.21/26 CV

No trades
See on Supercharts

Key terms


Outstanding amount
‪5.38 M‬USD
Face value
1,000.00USD
Minimum denomination
200,000.00USD
Coupon
0% (Zero)
Coupon frequency
Yield to maturity
−0.14%
Maturity date
Jan 22, 2026
Term to maturity
1 year

About HANSOH PHARMAC.21/26 CV


Sector
Health Technology
Home page
Issue date
Jan 22, 2021
ISIN
XS2284144339
FIGI
BBG00YT8MC78
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.